Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MoWith Klygefa approvals, AZ expands myasthenia gravis domain beyond Soliris, Ultomiris
MoRoche's Gazyva adds 3rd immune indication with first FDA nod for primary membranous nephropathy
Mo2026's Fiercest Women in Life Sciences
SoFDA rejects Summit's ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
SoGenentech brings every day wins to life in patient-focused Hemlibra push
SaThe Oral GLP-1 Tracker: Foundayo, Wegovy pill keep scripts on the ascent
13.11.Measurement Everywhere: Why the Future Can't Be Measured in the Rearview Mirror
13.11.Europe's CHMP backs Baxfendy, gives Hansoh's Aumseqa another chance
13.11.Teva CEO 'proud' of pipeline buzz as innovative-generics hybrid rolls out 1st R&D day
13.11.Bavarian Nordic C-suite stability in question as CFO steps down amid Q3 beat
13.11.Fierce Pharma Asia-China's Big Pharma ambition; Treasury's China crackdown; Takeda's narcolepsy launch
13.11.Sanofi teams with British comic Beano for Type 1 diabetes education push
13.11.Novo amps up Wegovy marketing with DJ Khaled spinning his weight-loss tale
12.11.Pharmas should stay agile as Democrats amp up scrutiny over Trump's MFN deals
12.11.FDA appears to pause controversial speedy review program, complete response letter disclosures
12.11.Orzeyful's 'lighter' DEA schedule paves way for Takeda's first-in-class narcolepsy launch
12.11.Radiopharma player PharmaLogic snaps up Lantheus' CDMO business, plant as Curium acquisition advances
12.11.AI models from Google, Anthropic and more lean on recommending promoted drugs: study
11.11.FDA cites record request breakdowns in trio of warning letters to API makers
11.11.Legend Biotech shares fall 16% after first earnings report under new CEO
11.11.BioNTech pays $205M for FDA voucher to speed up 'late-stage oncology pipeline'
11.11.Aurobindo unit Eugia recalls antibiotic lot, citing glass particle concerns
10.11.ImmunityBio juggles phase 3 win and 20% stock crash en route to Anktiva front-line expansion
10.11.Summit sheds commercial leaders ahead of ivonescimab's FDA decision
10.11.J&J readies Caplyta for FDA label expansion after 2nd phase 3 win in bipolar mania